Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03713944
Title Carboplatin Plus Pemetrexed Plus Atezolizumab Plus Bevacizumab in Chemotherapy and Immunotherapy-naïve Patients With Stage IV Non-squamous Non-small Cell Lung Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Big Ten Cancer Research Consortium
Indications

lung non-small cell carcinoma

Therapies

Atezolizumab + Bevacizumab + Carboplatin + Pemetrexed Disodium

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.